• MIZ1-TMBIM4 Axis Regulates IgG1+ Germinal Center B Cell Surv

  2026-04-24

  This study uncovers how the transcription factor MIZ1 and its downstream effector TMBIM4 uniquely sustain survival of IgG1+ germinal center B cells during positive selection. By dissecting isotype-specific dependencies in B cell fate, the work advances our understanding of affinity maturation and apoptosis regulation in humoral immunity.

• 4-Hydroxytamoxifen: Technical Guidance for Research Workflow

  2026-04-24

  4-Hydroxytamoxifen (SKU B6167) is a potent estrogen receptor modulator designed for research applications involving breast cancer, prostate cancer, and cardiac myocyte calcium handling. It is best suited for protocols requiring high purity and DMSO-based solubility, but is not appropriate for workflows needing aqueous or ethanol dissolution.

• IGF2BP1–THBS1–TLR4 Axis Drives Macrophage Fibrosis in Lung D

  2026-04-23

  This study elucidates how the m6A reader IGF2BP1 accelerates pulmonary fibrosis by stabilizing THBS1 mRNA, thereby promoting macrophage M2 polarization and glycolytic reprogramming via TLR4. These mechanistic insights clarify the epigenetic and metabolic drivers of fibrotic lung pathology and suggest new avenues for targeted intervention.

• Metformin Hydrochloride: Mechanisms and Research Protocols

  2026-04-23

  Metformin Hydrochloride (Metformin HCl) is a benchmark small molecule for dissecting glucose metabolism and type 2 diabetes mechanisms in preclinical models. It acts mainly by suppressing hepatic gluconeogenesis and modulating AMPK signaling. Recent evidence highlights its role in inhibiting pathological bone formation via Nr4a1/Wnt/β-catenin pathway suppression.

• iPSC-Based Platforms for Ultrarare Disease Drug Selection: I

  2026-04-22

  Sequiera et al. developed an induced pluripotent stem cell (iPSC)-based platform to personalize drug selection for an ultrarare Leigh-like syndrome patient with novel compound ECHS1 variants. This approach enabled ex vivo drug efficacy testing, supporting precision enrollment in clinical trials and highlighting the platform's potential to improve outcomes in ultrarare disease management.

• Streptavidin – Cy5: High-Sensitivity Biotin Detection in Onc

  2026-04-22

  Streptavidin – Cy5 sets a new standard for ultrasensitive, reproducible biotin detection in immunohistochemistry, immunofluorescence, and flow cytometry. Its Cy5 fluorescent dye conjugation empowers researchers to interrogate cell signaling and protein interactions with exceptional clarity, as demonstrated in advanced breast cancer apoptosis studies.

• Isradipine (Dynacirc) in Cell Assays: Precision, Purity, and

  2026-04-21

  This article explores real-world laboratory scenarios where Isradipine (Dynacirc), SKU A8453, addresses core challenges in cell viability, neuroprotection, and calcium signaling research. It provides evidence-based answers to experimental design, protocol optimization, and product selection, supporting reproducibility and data integrity for biomedical researchers.

• Rapamycin (Sirolimus): Applied mTOR Inhibition for Research

  2026-04-21

  Rapamycin (Sirolimus) is the definitive tool for dissecting mTOR-driven pathways in cancer, immunology, and mitochondrial disease research. This article demystifies advanced workflows, highlights troubleshooting strategies, and translates new mechanistic insights—empowering reproducibility and actionable outcomes with APExBIO’s validated formulation.

• Z-VAD-FMK for Precision Apoptosis Inhibition: Beyond Pathway

  2026-04-20

  Explore how Z-VAD-FMK enables advanced apoptosis inhibition and caspase activity measurement, with unique insights into its mechanistic applications in mitochondrial-targeted cancer research. Learn how this cell-permeable pan-caspase inhibitor transforms experimental design and interpretation.

• Fluconazole and the Frontiers of Antifungal Resistance Resea

  2026-04-20

  This thought-leadership article explores the mechanistic role of fluconazole as a fungal cytochrome P450 enzyme 14α-demethylase inhibitor and its transformative application in dissecting Candida albicans biofilm resistance. We synthesize recent findings on autophagy-driven resistance, provide protocol guidance, and offer strategic recommendations for translational researchers seeking to advance antifungal drug discovery beyond conventional paradigms. Distilling the latest evidence—including pivotal new insights on PP2A-mediated autophagy—we position APExBIO’s Fluconazole as a gold-standard research tool while mapping a future-ready research agenda.

• Saracatinib (AZD0530): Applied Workflows in Cancer Biology

  2026-04-19

  Saracatinib (AZD0530) enables precise inhibition of Src/Abl kinases, unlocking reproducible cancer cell proliferation and migration assays. This article maps experimental workflows, troubleshooting strategies, and protocol enhancements to maximize translational impact in cancer biology and beyond.

• Haloprogin: Innovation in Topical Antifungal and Antimicrobi

  2026-04-18

  This article reviews the foundational 1970 study establishing Haloprogin as a broad-spectrum topical antifungal with unique antimonilial and selective antibacterial properties. The research highlights its efficacy against dermatophytes and Candida, as well as Gram-positive bacteria, providing a technical basis for its continued use in experimental infection models and translational research.

• Guidelines for Diagnosis and Treatment of Cutaneous Candidia

  2026-04-17

  This article analyzes the 2009 Japanese guidelines for mucocutaneous candidiasis, emphasizing evidence-based diagnostic criteria and the efficacy of imidazole antifungals, particularly Neticonazole Hydrochloride, in topical therapy. The study’s structured approach to diagnosis and treatment offers clarity for clinical and translational research, with implications for optimizing antifungal protocols.

• Oridonin Modulates Osteoclastogenesis via MAPK/NF-κB Pathway

  2026-04-16

  This study demonstrates that oridonin attenuates thioacetamide-induced osteoclastogenesis by inhibiting the MAPK/NF-κB pathway and promotes osteoblast differentiation through the BMP-2/RUNX2 axis. These findings highlight a dual-action mechanism with significant implications for osteoporosis research and the development of targeted anti-inflammatory strategies.

• Ultrafiltration Enhances Circular RNA Purification for Thera

  2026-04-15

  Guillen-Cuevas et al. introduce ultrafiltration as a robust method for purifying circular RNA (circRNA), achieving substantially higher purity and yield compared to traditional chromatographic approaches. This work addresses a central obstacle in circRNA therapeutic development by enabling scalable, efficient separation of circular from linear RNA species.

15894 records 1/1060 page Next 12345 下5页 Last page